Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Life360, Inc. (LIF) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as a Nasdaq-listed issuer. Life360 is a family connection and safety company that reports its financial and operational performance through filings with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic reports.
In its SEC filings, Life360 presents details on subscription revenue, hardware revenue, and other revenue, which includes data and partnership revenue such as advertising. The company also discloses key performance indicators for its core mobile application, including Monthly Active Users (MAUs), Paying Circles, and Average Revenue Per Paying Circle. These metrics help investors understand the scale and engagement of Life360’s user base and the contribution of its core app to overall results.
Filings may also discuss gross margin, operating expenses, and Adjusted EBITDA, along with narrative explanations of changes in research and development, sales and marketing, and general and administrative costs. Life360 uses non-GAAP measures such as Adjusted EBITDA and core subscription revenue to supplement its GAAP results, and reconciliations are typically included in its financial disclosures.
Corporate actions and material events are reported through Forms such as Form 8-K. For example, an 8-K filed in November 2025 describes Life360’s announcement of financial results and its entry into an Agreement and Plan of Reorganization to acquire Nativo, Inc., an advertising technology company, in a transaction valued at approximately $120 million in cash and stock, subject to customary closing conditions. Such filings outline the structure of significant transactions, key terms, and the expected impact on the company.
On this page, Stock Titan surfaces Life360’s SEC filings as they are made available on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight the main points of lengthy documents, such as earnings releases, transaction announcements, and presentations furnished as exhibits, so readers can quickly grasp the context before reviewing the full text. Users can review current reports like Form 8-K for material events, and refer to Life360’s broader set of filings for a more complete view of its financial condition, risk factors, and governance practices.
For investors tracking LIF, the filings page is a central resource to monitor how Life360 describes its business performance, revenue mix, user metrics, and strategic transactions in its own words, directly from its official submissions to the SEC.
Life360, Inc. director John Coghlan reported sales, transfers and a charitable gift of company common stock. On 12/05/2025, the John Coghlan Living Trust sold 2,025 shares at a weighted average price of $76.82 and 1,100 shares at a weighted average price of $77.96, in each case under a Rule 10b5-1 trading plan adopted on December 6, 2024.
On 12/09/2025, he made a bona fide gift of 3,045 shares to a donor-advised fund for charitable purposes and transferred 3,045 shares between the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust in transactions described as exempt under Rule 16a-13.
Following these transactions, he beneficially owns 3,344 shares directly, 9,065 shares through the John Coghlan Living Trust and 55,494 shares through The John Philip Coghlan 2025 Grantor Retained Annuity Trust, including 1,672 restricted stock units that each represent one share upon vesting.
Life360, Inc.'s Chief Financial Officer reported a tax-related share withholding. On 12/04/2025, the issuer withheld 9,978 shares of common stock at $75.02 per share to satisfy income tax withholding and remittance obligations arising from the vesting and net settlement of previously granted restricted stock units, rather than an open-market sale.
After this transaction, the officer beneficially owned 88,254 shares of Life360 common stock directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust. These holdings also include 72,230 restricted stock units previously granted, each representing a contingent right to receive one share of common stock upon vesting.
Life360, Inc. reported that one of its directors sold common stock in the company. On 12/03/2025, the director sold 15,000 shares of Life360 common stock at a weighted average price of $74.19 per share, with individual trade prices ranging from $74.13 to $74.46. After this transaction, the director beneficially owns 56,809 shares indirectly through the Goines Wong Living Trust and 6,070 shares directly. The direct holdings include 2,339 restricted stock units, each representing the right to receive one share of common stock upon vesting.
Life360, Inc. (LIF) CEO and director reports a small stock sale under a preset trading plan. On 11/24/2025, the reporting person sold 4,546 shares of Life360 common stock at a price of $76.1 per share, coded as an "S" transaction. This sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024, which provides for automatic sales based on predetermined criteria and was put in place when the insider was not aware of material nonpublic information.
After this transaction, the insider beneficially owns 324,827 shares of Life360 common stock, including 222,277 restricted stock units that each represent a contingent right to receive one share upon vesting.
Life360, Inc. (LIF) Chief Financial Officer updates holdings and corrects prior option terms. The reporting person exercised a stock option and acquired 6,500 shares of Life360 common stock on 11/19/2025 at an exercise price of $3.58 per share. After the transaction, the reporting person directly held 98,232 common shares and indirectly held 72,553 shares through the Russell John Burke Revocable Trust.
The filing notes that 9,523 directly held shares were previously transferred to the revocable trust under an exemption from Section 16. It also states that 91,732 restricted stock units are included in the beneficial ownership total, each representing a right to receive one common share upon vesting. The stock option underlying this exercise is now fully vested and exercisable, and the vesting terms previously reported for this option were inadvertently misreported and are corrected in this filing.
Life360, Inc. (LIF) reported that one of its directors exercised and sold shares under a pre-arranged trading plan. On 11/13/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share and, on the same date, sold 7,930 shares of common stock at $76.93 per share. After these transactions, the director beneficially owned 105,456 shares of common stock, including 2,036 restricted stock units, and held 95,160 stock options. The filing notes that these trades were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, and it corrects the vesting commencement date of the reported stock option to April 1, 2024.
Life360, Inc. announced a planned acquisition of Nativo, Inc. via a Merger Agreement valued at approximately $120 million in a mix of cash and common stock. The transaction is subject to customary closing conditions and is expected to close in January 2026.
The company also furnished materials related to its results and investor communications, including a media release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) tied to a conference call and webcast on November 10, 2025 at 5:00 p.m. Eastern Time. A separate press release (Exhibit 99.3) announced the Nativo deal. These materials are furnished, not filed, under the Exchange Act.
Forward-looking statements highlight anticipated benefits and synergies from integrating Nativo, along with potential acceleration of Life360’s advertising strategy, while noting risks related to closing conditions, integration, and market factors.
Life360, Inc. reported stronger Q3 2025 results. Total revenue reached $124.5 million, up from $92.9 million a year ago, led by subscription revenue of $96.3 million. Gross profit was $97.1 million. Operating income improved to $5.7 million, and net income was $9.8 million, compared with $7.7 million in Q3 2024.
The company ended the quarter with cash and cash equivalents of $455.7 million. In June, Life360 issued $320.0 million of 0.00% convertible senior notes due 2030 and purchased capped calls for $33.7 million to mitigate potential dilution. Current deferred revenue was $46.1 million, and remaining performance obligations were $225.3 million. Channel concentration remained high, with Apple processing 54% of transactions and Google 21%. Legal overhang eased as the Tile patent case was settled at no cost, and certain class claims were dismissed with prejudice while others are stayed pending appeal.
Life360, Inc. (LIF) director John P. Coghlan reported open‑market sales on 11/03/2025 made under a Rule 10b5‑1 trading plan adopted on December 6, 2024. The transactions included 2,866 shares at a weighted average price of $98.88 and 259 shares at a weighted average price of $99.47.
Following the transactions, beneficial ownership reported included 15,235 shares held by the John Coghlan Living Trust, 3,344 shares held directly, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. Holdings include 2,508 restricted stock units. The filing also notes an exempt transfer of 12,110 shares from the GRAT to the Living Trust pursuant to Rule 16a‑13.
Life360, Inc. (LIF) Chief Executive Officer and Director reported a sale of 4,546 shares of common stock on 10/24/2025 at a price of $93.01 per share, coded “S.” The trade was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024.
Following the transaction, the reporting person beneficially owns 329,373 shares directly. This amount includes 222,277 restricted stock units (RSUs), each representing a contingent right to receive one share upon vesting.